Insulinoma other imaging findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{PSD}} | {{CMG}}{{AE}}{{PSD}} | ||
==Overview== | ==Overview== | ||
Other imaging studies for insulinoma include | Other imaging studies for insulinoma include indium-111 pentetreotide scan. | ||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
Other imaging studies for insulinoma include: | Other imaging studies for insulinoma include: | ||
===Indium-111 Pentetreotide Scan=== | ===Indium-111 Pentetreotide Scan=== | ||
* | *Indium-111 pentetreotide scan is more sensitive than [[ultrasound]]. | ||
==References== | ==References== | ||
Revision as of 23:11, 7 October 2015
|
Insulinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Insulinoma other imaging findings On the Web |
|
American Roentgen Ray Society Images of Insulinoma other imaging findings |
|
Risk calculators and risk factors for Insulinoma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Other imaging studies for insulinoma include indium-111 pentetreotide scan.
Other Imaging Findings
Other imaging studies for insulinoma include:
Indium-111 Pentetreotide Scan
- Indium-111 pentetreotide scan is more sensitive than ultrasound.